Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Fig. 3

Genomic alterations identified in NSCLC patients at resistance to TKIs. Frequency of genomic alterations in paired samples of MET-TKI-treated (a) or EGFR-TKI-treated (b) NSCLC patients. Each column represents one patient. The clinical characteristics of patients are shown at the top. The frequency of each gene alteration pre- and post-treatment is listed to the left of the heatmap

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us